new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Dyax Corp
Dyax Corporation
Dyax Corp A Delaware Corporation
Dyax Corp_20131212
Dyax Corp A Massachusetts Corporation
  

Dyax Corp patents

Recent patent applications related to Dyax Corp. Dyax Corp is listed as an Agent/Assignee. Note: Dyax Corp may have other listings under different names/spellings. We're not affiliated with Dyax Corp, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dyax Corp-related inventors




Date Dyax Corp patents (updated weekly) - BOOKMARK this page
10/20/16Fc receptor binding proteins
03/11/10Antibodies
01/05/17Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
12/15/16Prevention and reduction of blood loss
12/08/16Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
12/01/16Polynucleotides encoding an actriib antibody
09/01/16Assays for determining plasma kallikrein system biomarkers
09/01/16Diagnosis and treatment of autoimmune diseases
08/04/16Fc receptor binding proteins
08/04/16Fc receptor binding proteins
08/04/16Fc receptor binding proteins
08/04/16Fc receptor binding proteins
08/04/16Fc receptor binding proteins
07/07/16Fc receptor binding proteins
04/14/16Plasma kallikrein binding proteins
02/11/16Multi-chain eukaryotic display vectors and uses thereof
01/21/16Anti-plasma kallikrein antibodies
12/31/15Multivalent constructs for therapeutic and diagnostic applications
12/24/15Compositions and methods for treating ophthalmic disorders
12/17/15Evaluation, assays and treatment of pkal-mediated disorders
12/17/15Evaluation and treatment of bradykinin-mediated disorders
10/01/15Compositions and methods for treatment of diabetic macular edema
08/06/15Peptides that specifically bind hgf receptor (cmet) and uses thereof
06/11/15Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
03/26/15Ligand screening and discovery
01/22/15Anti mif antibodies
11/13/14Plasma kallikrein binding proteins
11/13/14Combination therapy comprising an mmp-14 binding protein
10/16/14Fc receptor binding proteins
10/09/14Plasma kallikrein binding proteins
09/25/14Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/25/14Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/04/14Fc receptor binding proteins
08/07/14Binding molecules for human factor viii and factor viii-like proteins
07/17/14Novel fab fragment libraries and methods for their use
05/15/14Display library process
04/17/14Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
01/16/14Focused libraries of genetic packages
12/12/13Multi-chain eukaryotic display vectors and uses thereof
10/17/13Ligand screening and discovery
09/19/13Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
07/25/13Tracking and reporting information characterizing attacks caused by a disease
07/11/13Focused libraries of genetic packages
03/28/13Fc receptor binding proteins
02/21/13Fc receptor binding proteins
02/14/13Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
01/10/13Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
12/27/12Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/20/12Poly-pegylated protease inhibitors
11/29/12Focused libraries of genetic packages
08/09/12Plasma kallikrein binding proteins
06/07/12Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
05/03/12Metalloproteinase binding proteins
02/23/12Binding molecules for human factor viii and factor viii-like proteins
02/02/12Hk1-binding proteins
02/02/12Metalloproteinase 9 binding proteins
02/02/12Focused libraries of genetic packages
01/19/12Kallikrein-inhibitor therapies
12/22/11Peptides that specifically bind hgf receptor (cmet) and uses thereof
12/08/11Metalloproteinase 9 and metalloproteinase 2 binding proteins
11/24/11Multi-chain eukaryotic display vectors and uses thereof
11/17/11Multi-chain eukaryotic display vectors and uses thereof
11/17/11Multi-chain eukaryotic display vectors and uses thereof
10/27/11Combination treatments comprising protease binding proteins for inflammatory disorders
10/27/11Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
Patent Packs
08/18/11Plasma kallikrein binding proteins
08/04/11Multi-chain eukaryotic display vectors and uses thereof
07/14/11Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
07/14/11Poly-pegylated protease inhibitors
06/23/11Inhibitors of human plasmin derived from the kunitz domains
06/09/11Metalloproteinase 9 and metalloproteinase 2 binding proteins
06/09/11Kallikrein-binding "kunitz domain" proteins and analogues thereof
04/14/11Prevention and reduction of blood loss
04/07/11Libraries of genetic packages comprising novel hc cdr3 designs
03/10/11Tie complex binding proteins
01/13/11Methods for preserving organs and tissues
11/18/10Metalloproteinase-binding proteins
11/18/10Focused libraries of genetic packages
11/18/10Binding molecules for human factor viii and factor viii-like proteins
10/28/10Compositions and methods for treating ophthalmic disorders
Patent Packs
10/21/10Metalloproteinase binding proteins
10/21/10Antibodies against the ectodomain of erbb3 and uses thereof
10/14/10Anti mif antibodies
08/05/10Method of inhibition of vascular development using an antibody
07/22/10Treatment of mucositis with kallikrein inhibitors
03/04/10Antibodies against erbb3 and uses thereof
12/17/09Metalloproteinase 12 binding proteins
12/17/09Metalloproteinase 9 binding proteins
12/03/09Metalloproteinase 9 and metalloproteinase 2 binding proteins
11/05/09Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/01/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/17/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/17/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/17/09Administration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
09/17/09Directed evolution of novel binding proteins
09/10/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/10/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/03/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
08/27/09Methods for producing specific binding pairs
08/13/09Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
07/23/09Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
06/25/09Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
03/26/09Prevention and reduction of blood loss
02/05/09Inhibitors of human plasmin derived from the kunitz domains
02/05/09Inhibitors of human plasmin derived from the kunitz domains
12/12/13Multi-chain eukaryotic display vectors and uses thereof
10/22/09Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
04/23/09Ligand screening and discovery







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dyax Corp in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dyax Corp with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';